Skip to main content
Smart Investors Daily
EH

NYSE · EHC

Encompass Health Corporation

Healthcare · Medical - Care Facilities

$134.79

Up+$5.59 (+4.15%)

Updated Nov 4, 2026, 6:57 PM

SID Score

6.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
10.75B
P/E ratio
19.85
Dividend yield
0.66%
52-week range
$92.77 – $139.12
Volume
1.38M
Avg. volume
837.24K

Price performance · EHC

EHC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

EHC closed at $134.79 after 21 trading sessions, up 8.10% for the selected period.

Last close
$134.79
Period change
+8.10%
Period low
$120.47
Period high
$137.19
Daily close
View OHLC price history
EHC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$136.83$139.12$134.79$134.791.38M
Nov 2, 2026$136.31$138.35$134.56$137.191.58M
Oct 30, 2026$134.53$137.27$132.44$135.901.8M
Oct 29, 2026$133.08$133.7487$126.91$131.492.2M
Oct 28, 2026$121.12$123.31$121.12$122.091.01M
Oct 27, 2026$123.53$124.455$120.95$121.53727.12K
Oct 26, 2026$124.10$126.585$123.47$124.10843.86K
Oct 23, 2026$125.47$125.51$123.098$124.09805.86K
Oct 22, 2026$121.13$126.37$119.91$126.011.23M
Oct 21, 2026$121.28$122.25$120.03$120.471.22M
Oct 20, 2026$122.73$123.45$119.7689$121.671.39M
Oct 19, 2026$126.79$128.3799$121.51$121.712.26M
Oct 16, 2026$129.13$129.355$126.86$127.871.3M
Oct 15, 2026$128.74$129.9599$127.50$127.771.11M
Oct 14, 2026$124.88$126.66$124.705$126.56737.68K
Oct 13, 2026$125.32$125.32$123.66$124.33606.75K
Oct 12, 2026$123.68$126.36$123.68$124.421.06M
Oct 9, 2026$122.21$124.23$121.43$123.33604.38K
Oct 8, 2026$122.35$123.585$121.94$122.54895.73K
Oct 7, 2026$124.86$125.55$121.99$122.48875.47K
Oct 6, 2026$121.93$124.9054$120.98$124.691.3M

Latest EHC news

The latest Smart Investors Daily articles mentioning EHC.

EHC research

Overview

Company profile and research snapshot.

Company profile

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$146.67
Implied upside
—
Analysts
—
EHC recent ratings
DateFirmRatingTarget
Oct 30, 2026UBSBuy—
Oct 30, 2026Truist SecuritiesBuy—
Oct 30, 2026TD CowenBuy—
Oct 30, 2026KeybancOverweight—
Oct 29, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 31, 2026

What Encompass Health Stock Guidance Raise Means For Shareholders

Encompass Health reported third quarter 2026 net operating revenue of US$1,609.5 million and net income of US$149.9 million, then modestly raised full year 2026 revenue guidance to a range of US$6,450 million to US$6,500 million and affirmed a quarterly dividend of US$0.21 per share. The business is pairing higher earnings per share from continuing operations with continued build out of inpatient rehabilitation capacity in Texas, indicating management focus on both near term profitability...

Yahoo · Oct 31, 2026

Encompass Health (EHC) Could Be 9% Undervalued As Q3 Earnings Lifted 2026 Guidance

Encompass Health (EHC) just posted third quarter 2026 results that showed higher sales, net income and earnings per share compared with a year earlier, and then followed up by nudging full year revenue guidance higher. That backdrop has fed into the recent rally in Encompass Health, with the share price logging a 3.35% 1-day move and a 22.36% 90-day share price return. Total shareholder return over 1 and 5 years of 20.25% and 175.91% respectively points to momentum that investors are still...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.